Research study on narcolepsy experiences and follow-up
Part of Brain & nervous system, Mental health clinical trials.
This study asks adults with narcolepsy about their experiences during regular check-ins and electronic reporting. It may help researchers better understand what patients go through and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Be willing and able to follow the study schedule and check-ins
- Be able to use electronic reporting (online or app-based updates)
- Be willing to sign written consent before joining
- Not be pregnant, planning pregnancy, or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is a registry (a study database) that collects information from children and teens with narcolepsy. It helps researchers better understand the condition and who is affected, which can support future studies.
This study compares “social cognition” (how people recognize and understand others’ thoughts and feelings) in adults with narcolepsy or idiopathic hypersomnia. It may help researchers better understand how these conditions can affect everyday social interactions.
This study follows people with frequent daytime sleepiness (sometimes from narcolepsy or hypersomnia) and compares them with matched healthy people, including some with sleep apnea. The goal is to better understand what causes sleepiness and to improve how these conditions are recognized and measured.
This study looks at how narcolepsy or idiopathic hypersomnia affects thinking and cardiovascular health, and how usual treatment medications may change those outcomes. It may help researchers understand risks and benefits of common hypersomnia therapies.
This study looks at the genes and health of people with narcolepsy (types 1 and 2) who are Black or North African, to better understand the condition and find potential treatments.
This study tests a new drug called E2086 to see if it can help reduce daytime sleepiness and sudden muscle weakness in adults with narcolepsy. It involves two groups: people with cataplexy (type 1) and those without (type 2).
Hear when a new Narcolepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.